Evercore ISI initiated coverage of Hinge Health with a rating of Outperform and set a new price target of $50.00
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/14/2025 | $58.00 | Mkt Outperform | Citizens JMP |
| 6/16/2025 | Outperform | William Blair | |
| 6/16/2025 | $48.00 | Buy | Truist |
| 6/16/2025 | $48.00 | Buy | Stifel |
| 6/16/2025 | $45.00 | Outperform | Raymond James |
| 6/16/2025 | $41.00 | Overweight | Piper Sandler |
| 6/16/2025 | $46.00 | Overweight | Morgan Stanley |
| 6/16/2025 | $47.00 | Buy | Needham |
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w
Combined with Hinge Health's AI-powered exercise therapy program, HingeSelect adds access to high-quality in-person providers for members at up to 50% below PPO rates Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health's technology and in-house orthopedic physicians triage and direct downstream care, prioritizing the most appropriate evidence-based treatment. When in-person care, such as imaging or injections is required, members are seamlessly connected to pre-vetted providers at up to 50% below PPO rates. Combined with Hinge Health's AI-powered digital exercise therapy, HingeSelect pr
Methodology validated by leading global benefits consultant Hinge Health, Inc. (NYSE:HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic musculoskeletal (MSK) conditions and a 2.4x return on investment (ROI) for fully insured health plan members using its digital MSK platform. The methodology of the medical claims analysis of 4,788 health plan members was validated by Gallagher, a leading global insurance brokerage, risk management, and consulting firm. MSK costs remain one of the top drivers of health costs, placing increasing pressure on benefits leaders to ensure programs deliver value and cost-effic
Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00
William Blair initiated coverage of Hinge Health with a rating of Outperform
Truist initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00
Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w